AI in Nuclear Medicine: Improvements in the Field
AI in Nuclear Medicine: Improvements in the Field
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
Beyond the Surface: The Impact of Psoriasis on Cardiovascular Health
Beyond the Surface: The Impact of Psoriasis on Cardiovascular Health
How Artificial Sweeteners Could Be Linked to Heart Disease
How Artificial Sweeteners Could Be Linked to Heart Disease
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
Effects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
MACE and SGLT2 Inhibitors: Do They Have an Impact?
MACE and SGLT2 Inhibitors: Do They Have an Impact?
Staging Coronary Risk: A New TRANSFORMative Approach
Staging Coronary Risk: A New TRANSFORMative Approach
TRANSFORM Trial: Overview and Potential Implications
TRANSFORM Trial: Overview and Potential Implications
Deep Learner: Building AI to Improve Cardiovascular Care
Deep Learner: Building AI to Improve Cardiovascular Care
Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Conversations With Cardiologists: Clinical Perspectives on the Treatment of HFmrEF and HFpEF
Conversations With Cardiologists: Clinical Perspectives on the Treatment of HFmrEF and HFpEF
Primary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Primary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Reshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy
Reshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy